Potassium tert-butoxide → (S)-2'-bromo-7'-iodospiro[morpholine-3,9'-xanthen]-5-one
Reaction equation
[Br:1][C:2]1[CH:15]=[CH:14][C:13]2[O:12][C:11]3[C:6](=[CH:7][C:8]([I:16])=[CH:9][CH:10]=3)[C@:5]([NH:19][C:20](=[O:23])[CH2:21]Cl)([CH2:17][OH:18])[C:4]=2[CH:3]=1.CC(C)([O-])C.[K+]>C(O)(CC)(C)C>[Br:1][C:2]1[CH:15]=[CH:14][C:13]2[O:12][C:11]3[C:6](=[CH:7][C:8]([I:16])=[CH:9][CH:10]=3)[C@:5]3([CH2:17][O:18][CH2:21][C:20](=[O:23])[NH:19]3)[C:4]=2[CH:3]=1Participants
4
Procedure
In a 500-mL flask (S)—N-(2-bromo-9-(hydroxymethyl)-7-iodo-9H-xanthen-9-yl)-2-chloroacetamide (4.52 g, 8.89 mmol) was dissolved in t-amyl alcohol (125 mL). Potassium t-butoxide (2.244 g, 20.00 mmol) was added. After 14 h, the reaction was concentrated. The residue was taken up in dilute aqueous NH4Cl (50 mL) and the aqueous phase was extracted with 5% MeOH-DCM (3×133 mL). The organics were combined, washed with dilute brine (25 mL), dried over sodium sulfate and concentrated. The material was purified through silica gel (500 mL) using 30% EtOAc-hexane to afford (S)-2′-bromo-7′-iodospiro[morpholine-3,9′-xanthen]-5-one (1.92 g, 4.07 mmol).
Workup
- concentrationthe reaction was concentrated
- extractionthe aqueous phase was extracted with 5% MeOH-DCM (3×133 mL)
- washwashed with dilute brine (25 mL)
- dry with materialdried over sodium sulfate
- concentrationconcentrated
- customThe material was purified through silica gel (500 mL)
Sources & evidence
- ORD record
- ord-fe103aa7e5bc45b68dab4e69e89e8aa8
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09296759B2
Reaction notes
Loading…